Orbitofacial neurofibromatosis: Clinical characteristics and treatment outcome

I. A. Chaudhry, J. Morales, F. A. Shamsi, W. Al-Rashed, E. Elzaridi, Y. O. Arat, C. Jacquemin, D. T. Oystreck, Thomas Bosley

Research output: Contribution to journalArticle

Abstract

Purpose To report clinical observations and surgical management in a large series of patients with orbitofacial neurofibromatosis type 1 (OFNF). Patients and methods Patients were identified and medical records reviewed for demographic data, ophthalmologic examinations, surgical interventions, and procedure outcome to create a retrospective, non-comparative case series of patients with OFNF seen at one medical centre over a 23-year period. Results Sixty patients with OFNF (31 females and 29 males; mean age, 14 years) were followed for an average of 5.7 years. Presenting signs and symptoms included eyelid swelling in all patients, ptosis in 56 (93.3%), proptosis in 34 (56.6%), dystopia or strabismus in 30 (50%), and decreased visual acuity in 50 (83.3%). Surgical intervention included ptosis repair in 54 (90%; mean 1.6 surgical procedures), facial and orbital tumour debulking in 54 (90%; mean 2.3 surgeries), and canthoplasty in 28 (46.6%) patients. Eleven patients required enucleation or exenteration of a blind eye. Conclusion Patients with OFNF often require multiple procedures to preserve vision, prevent additional disfigurement, and achieve cosmetic rehabilitation. Patients need regular ophthalmological monitoring given the potential for progressive visual and cosmetic consequences.

Original languageEnglish (US)
Pages (from-to)583-592
Number of pages10
JournalEye
Volume26
Issue number4
DOIs
StatePublished - Apr 2012
Externally publishedYes

Fingerprint

Neurofibromatoses
Neurofibromatosis 1
Cosmetics
Exophthalmos
Strabismus
Eyelids
Visual Acuity
Signs and Symptoms
Medical Records
Rehabilitation
Demography

Keywords

  • neurofibromatosis type 1
  • optic pathway glioma
  • orbitofacial neurofibromatosis
  • plexiform neurofibromas
  • sphenoid dysplasia

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Chaudhry, I. A., Morales, J., Shamsi, F. A., Al-Rashed, W., Elzaridi, E., Arat, Y. O., ... Bosley, T. (2012). Orbitofacial neurofibromatosis: Clinical characteristics and treatment outcome. Eye, 26(4), 583-592. https://doi.org/10.1038/eye.2011.336

Orbitofacial neurofibromatosis : Clinical characteristics and treatment outcome. / Chaudhry, I. A.; Morales, J.; Shamsi, F. A.; Al-Rashed, W.; Elzaridi, E.; Arat, Y. O.; Jacquemin, C.; Oystreck, D. T.; Bosley, Thomas.

In: Eye, Vol. 26, No. 4, 04.2012, p. 583-592.

Research output: Contribution to journalArticle

Chaudhry, IA, Morales, J, Shamsi, FA, Al-Rashed, W, Elzaridi, E, Arat, YO, Jacquemin, C, Oystreck, DT & Bosley, T 2012, 'Orbitofacial neurofibromatosis: Clinical characteristics and treatment outcome', Eye, vol. 26, no. 4, pp. 583-592. https://doi.org/10.1038/eye.2011.336
Chaudhry IA, Morales J, Shamsi FA, Al-Rashed W, Elzaridi E, Arat YO et al. Orbitofacial neurofibromatosis: Clinical characteristics and treatment outcome. Eye. 2012 Apr;26(4):583-592. https://doi.org/10.1038/eye.2011.336
Chaudhry, I. A. ; Morales, J. ; Shamsi, F. A. ; Al-Rashed, W. ; Elzaridi, E. ; Arat, Y. O. ; Jacquemin, C. ; Oystreck, D. T. ; Bosley, Thomas. / Orbitofacial neurofibromatosis : Clinical characteristics and treatment outcome. In: Eye. 2012 ; Vol. 26, No. 4. pp. 583-592.
@article{db6f23d5bc8446df8e214b35697aef87,
title = "Orbitofacial neurofibromatosis: Clinical characteristics and treatment outcome",
abstract = "Purpose To report clinical observations and surgical management in a large series of patients with orbitofacial neurofibromatosis type 1 (OFNF). Patients and methods Patients were identified and medical records reviewed for demographic data, ophthalmologic examinations, surgical interventions, and procedure outcome to create a retrospective, non-comparative case series of patients with OFNF seen at one medical centre over a 23-year period. Results Sixty patients with OFNF (31 females and 29 males; mean age, 14 years) were followed for an average of 5.7 years. Presenting signs and symptoms included eyelid swelling in all patients, ptosis in 56 (93.3{\%}), proptosis in 34 (56.6{\%}), dystopia or strabismus in 30 (50{\%}), and decreased visual acuity in 50 (83.3{\%}). Surgical intervention included ptosis repair in 54 (90{\%}; mean 1.6 surgical procedures), facial and orbital tumour debulking in 54 (90{\%}; mean 2.3 surgeries), and canthoplasty in 28 (46.6{\%}) patients. Eleven patients required enucleation or exenteration of a blind eye. Conclusion Patients with OFNF often require multiple procedures to preserve vision, prevent additional disfigurement, and achieve cosmetic rehabilitation. Patients need regular ophthalmological monitoring given the potential for progressive visual and cosmetic consequences.",
keywords = "neurofibromatosis type 1, optic pathway glioma, orbitofacial neurofibromatosis, plexiform neurofibromas, sphenoid dysplasia",
author = "Chaudhry, {I. A.} and J. Morales and Shamsi, {F. A.} and W. Al-Rashed and E. Elzaridi and Arat, {Y. O.} and C. Jacquemin and Oystreck, {D. T.} and Thomas Bosley",
year = "2012",
month = "4",
doi = "10.1038/eye.2011.336",
language = "English (US)",
volume = "26",
pages = "583--592",
journal = "Eye",
issn = "0950-222X",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Orbitofacial neurofibromatosis

T2 - Clinical characteristics and treatment outcome

AU - Chaudhry, I. A.

AU - Morales, J.

AU - Shamsi, F. A.

AU - Al-Rashed, W.

AU - Elzaridi, E.

AU - Arat, Y. O.

AU - Jacquemin, C.

AU - Oystreck, D. T.

AU - Bosley, Thomas

PY - 2012/4

Y1 - 2012/4

N2 - Purpose To report clinical observations and surgical management in a large series of patients with orbitofacial neurofibromatosis type 1 (OFNF). Patients and methods Patients were identified and medical records reviewed for demographic data, ophthalmologic examinations, surgical interventions, and procedure outcome to create a retrospective, non-comparative case series of patients with OFNF seen at one medical centre over a 23-year period. Results Sixty patients with OFNF (31 females and 29 males; mean age, 14 years) were followed for an average of 5.7 years. Presenting signs and symptoms included eyelid swelling in all patients, ptosis in 56 (93.3%), proptosis in 34 (56.6%), dystopia or strabismus in 30 (50%), and decreased visual acuity in 50 (83.3%). Surgical intervention included ptosis repair in 54 (90%; mean 1.6 surgical procedures), facial and orbital tumour debulking in 54 (90%; mean 2.3 surgeries), and canthoplasty in 28 (46.6%) patients. Eleven patients required enucleation or exenteration of a blind eye. Conclusion Patients with OFNF often require multiple procedures to preserve vision, prevent additional disfigurement, and achieve cosmetic rehabilitation. Patients need regular ophthalmological monitoring given the potential for progressive visual and cosmetic consequences.

AB - Purpose To report clinical observations and surgical management in a large series of patients with orbitofacial neurofibromatosis type 1 (OFNF). Patients and methods Patients were identified and medical records reviewed for demographic data, ophthalmologic examinations, surgical interventions, and procedure outcome to create a retrospective, non-comparative case series of patients with OFNF seen at one medical centre over a 23-year period. Results Sixty patients with OFNF (31 females and 29 males; mean age, 14 years) were followed for an average of 5.7 years. Presenting signs and symptoms included eyelid swelling in all patients, ptosis in 56 (93.3%), proptosis in 34 (56.6%), dystopia or strabismus in 30 (50%), and decreased visual acuity in 50 (83.3%). Surgical intervention included ptosis repair in 54 (90%; mean 1.6 surgical procedures), facial and orbital tumour debulking in 54 (90%; mean 2.3 surgeries), and canthoplasty in 28 (46.6%) patients. Eleven patients required enucleation or exenteration of a blind eye. Conclusion Patients with OFNF often require multiple procedures to preserve vision, prevent additional disfigurement, and achieve cosmetic rehabilitation. Patients need regular ophthalmological monitoring given the potential for progressive visual and cosmetic consequences.

KW - neurofibromatosis type 1

KW - optic pathway glioma

KW - orbitofacial neurofibromatosis

KW - plexiform neurofibromas

KW - sphenoid dysplasia

UR - http://www.scopus.com/inward/record.url?scp=84859770421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859770421&partnerID=8YFLogxK

U2 - 10.1038/eye.2011.336

DO - 10.1038/eye.2011.336

M3 - Article

C2 - 22193879

AN - SCOPUS:84859770421

VL - 26

SP - 583

EP - 592

JO - Eye

JF - Eye

SN - 0950-222X

IS - 4

ER -